Grant: Engage Grants Program
University of Victoria
$25,000.00
Development of treatments for apicomplexa poultry pathogens****
EF 2018-19
Résumé
Amongst infectious diseases, coccidiosis and necrotic enteritis are two of the leading causes of morbidity and mortality in poultry. Worldwide, each disease causes greater than $5 billion dollars in poultry production losses annually. Canadian losses are estimated to be 10% of the US at 60 million USD. Poultry coccidiosis is cause by parasites from the genus Eimeria, most commonly Eimeria tenella, while Eimeria maxima is the most common predisposing factor for the development of poultry necrotic enteritis. Although vaccines exist for both conditions, they currently fail to adequately control the disease. NovoBind Livestock Therapeutics Inc. proposes to develop novel antibody-based strategies that could be incorporated into poultry feed to prevent the development of coccidiosis and necrotic enteritis. *Eimeria tenella and Eimeria maxima are part of a larger group of parasites known as apicomplexan parasites. This proposal relies on the expertise of Dr. Martin Boulanger and his laboratory in the key determinants of apicomplexan diseases. The work described here will enable NovoBind to generate antibodies targeting this key determinant and will bolster the novel Eimeria tenella-specific and Eimeria maxima-specific antibodies (NBXs) NovoBind has already generated. The development of prophylactic products targeting coccidiosis and necrotic enteritis would benefit poultry producers in Canada and around the world. The revenue generated by NovoBind in delivering this product would also be an economic boost to Canada. Furthermore, if successful this work will set the stage to develop similar therapeutics for human diseases caused by apicomplexan parasites, which include malaria and toxoplasmosis.*
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
537778-2018
Name nom
Boulanger, Martin
Department département
Biochemistry and Microbiology
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Development of treatments for apicomplexa poultry pathogens****
Keyword
NSERC
Application summary
Amongst infectious diseases, coccidiosis and necrotic enteritis are two of the leading causes of morbidity and mortality in poultry. Worldwide, each disease causes greater than $5 billion dollars in poultry production losses annually. Canadian losses are estimated to be 10% of the US at 60 million USD. Poultry coccidiosis is cause by parasites from the genus Eimeria, most commonly Eimeria tenella, while Eimeria maxima is the most common predisposing factor for the development of poultry necrotic enteritis. Although vaccines exist for both conditions, they currently fail to adequately control the disease. NovoBind Livestock Therapeutics Inc. proposes to develop novel antibody-based strategies that could be incorporated into poultry feed to prevent the development of coccidiosis and necrotic enteritis. *Eimeria tenella and Eimeria maxima are part of a larger group of parasites known as apicomplexan parasites. This proposal relies on the expertise of Dr. Martin Boulanger and his laboratory in the key determinants of apicomplexan diseases. The work described here will enable NovoBind to generate antibodies targeting this key determinant and will bolster the novel Eimeria tenella-specific and Eimeria maxima-specific antibodies (NBXs) NovoBind has already generated. The development of prophylactic products targeting coccidiosis and necrotic enteritis would benefit poultry producers in Canada and around the world. The revenue generated by NovoBind in delivering this product would also be an economic boost to Canada. Furthermore, if successful this work will set the stage to develop similar therapeutics for human diseases caused by apicomplexan parasites, which include malaria and toxoplasmosis.*